After being extremely involved in her grandfathers journey with Parkinsons disease and end-of-life care, Dr
Find it under Clinical Practice --- General: To view or add a comment, sign in Akums Drugs& Pharmaceuticals Ltd has launched a DCGI-approved triple-action capsule for the #treatment of diabetic peripheral neuropathic pain associated with vitamin B12 deficiency, expanding its #portfolio of differentiated therapies for neurological disorders
Ideal candidates include patients experiencing persistent fatigue unresponsive to sleep and oral supplementation, chronic pain conditions with inflammatory components, hormonal imbalances often combined with HRT evaluation, frequent illness or prolonged recovery from infection, high physical or cognitive performance demands, digestive conditions that impair oral nutrient absorption, or patients preparing for or recovering from regenerative medicine procedures
Cham: Humana Press
But if your next marathon is your goal race and you're chasing a PR or Boston Qualifier, consider waiting until after race day to start GLP-1 therapy
